產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-CPLA2/PLA2G4A抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-CPLA2/PLA2G4A抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-CPLA2/PLA2G4A
Cat. Number:
Anti-CPLA2/PLA2G4A抗體KL-7560R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
This gene encodes a member of the cytosolic phospholipase A2 group IV family. The enzyme catalyzes the hydrolysis of membrane phospholipids to release arachidonic acid which is subsequently metabolized intoAnti-CPLA2/PLA2G4A抗體 eicosanoids. Eicosanoids, including prostaglandins and leukotrienes, are lipid-based cellular hormones that regulate hemodynamics, inflammatory responses, and other intracellular pathways. The hydrolysis reaction also produces lysophospholipids that are converted into platelet-activating factor. The enzyme is activated by increased intracellular Ca(2+) levels and phosphorylation, resulting in its translocation from the cytosol and nucleus to perinuclear membrane vesicles. [provided by RefSeq, Jul 2008].
Also known as:
Calcium dependent Anti-CPLA2/PLA2G4A抗體phospholipid binding protein; CPLA 2; cPLA2 alpha; cPLA2; Cytosolic phospholipase A2; Cytosolic phospholipase A2 group IVA; Lysophospholipase; MGC126350; PA24A_HUMAN; Phosphatidylcholine 2 acylhydrolase; Phosphatidylcholine 2-acylhydrolase; Phospholipase A2 group 4 A; Phospholipase A2 group IVA (cytosolic calcium dependent); Phospholipase A2 group IVA; PhospholipaseA2; PLA2G4.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Dog, Pig, Rabbit, .
●
Immunogen: KLH conjugated synthetic peptide derived from human CPLA2.
●
Predicted Molecular Anti-CPLA2/PLA2G4A抗體Weight: 82kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions Anti-CPLA2/PLA2G4A抗體must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions Anti-CPLA2/PLA2G4A抗體must be determined by the end user.
kl833Mu02 補(bǔ)體因子D(CFD)多克隆抗體 Polyclonal Antibody to Complement Factor D (CFD)
kl837Mu02 白介素2受體α(IL2Rα)多克隆抗體 Polyclonal Antibody to Interleukin 2 Receptor Alpha (IL2Ra)
kl838Mu01 毒蕈堿型膽堿受體M3(CHRM3)多克隆抗體 Polyclonal Antibody to Cholinergic Receptor, Muscarinic 3 (CHRM3)
kl838Mu02 毒蕈堿型膽堿受體M3(CHRM3)多克隆抗體 Polyclonal Antibody to Cholinergic Receptor, Muscarinic 3 (CHRM3)
kl839Mu02 紐蛋白(VCL)多克隆抗體 Polyclonal Antibody to Vinculin (VCL)
kl845Mu02 CD83分子(CD83)多克隆抗體 Polyclonal Antibody to Cluster Of Differentiation 83 (CD83)
kl846Hu01 基質(zhì)金屬蛋白酶17(MMP17)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 17 (MMP17)
kl848Mu01 核因子κB抑制因子α(IκBα)多克隆抗體 Polyclonal Antibody to Inhibitory Subunit Of NF Kappa B Alpha (IkBa)
kl848Mu02 核因子κB抑制因子α(IκBα)多克隆抗體 Polyclonal Antibody to Inhibitory Subunit Of NF Kappa B Alpha (IkBa)
kl852Ra01 含Rho關(guān)聯(lián)卷曲螺旋蛋白激酶2(Rock2)多克隆抗體 Polyclonal Antibody to Rho Associated Coiled Coil Containing Protein Kinase 2 (Rock2)
kl853Mu02 基質(zhì)金屬蛋白酶19(MMP19)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 19 (MMP19)
kl859Mu02 凝集素樣氧化低密度脂蛋白受體1(LOX1)多克隆抗體 Polyclonal Antibody to Lectin Like Oxidized Low Density Lipoprotein Receptor 1 (LOX1)
kl860Bo01 胎球蛋白B(FETUB)多克隆抗體 Polyclonal Antibody to Fetuin B (FETUB)
kl867Mu02 表皮生長(zhǎng)因子受體2(EGFR2)多克隆抗體 Polyclonal Antibody to Epidermal Growth Factor Receptor 2 (EGFR2)
kl868Mu02 金屬硫蛋白2(MT2)多克隆抗體 Polyclonal Antibody to Metallothionein 2 (MT2)
kl873Mu02 CD19分子(CD19)多克隆抗體 Polyclonal Antibody to Cluster Of Differentiation 19 (CD19)
